Blog - Page 3065 of 5752

MondayJun 17, 2013 1:41 pm

CEO of MELA Sciences, Inc. (MELA) Resigns, Robert Coradini to Fill in Temporarily

MELA Sciences, a medical device company and developer of MelaFind(R), announced today that Joseph Gulfo has resigned as Chairman, President, Chief Executive Officer, and member of the Board of Directors. Member of the Board of Directors since December 2011, Robert Coradini will serve as interim CEO while the board hunts for a new Chief Executive Officer. Coradini has over 20 years of experience in the health care industry both leading and managing businesses for Johnson & Johnson and GE Medical Systems, now known as GE Healthcare. While at Johnson & Johnson, Coradini held a variety of senior leadership positions. Acting…

MondayJun 17, 2013 11:36 am

VistaGen Therapeutics, Inc. (VSTA) Shares Exciting CardioSafe 3D™ and LiverSafe 3D™ Developments at ISSCR’s 11th Annual Meeting

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, recently delivered an overview of key developments involving its CardioSafe 3D™ and LiverSafe 3D™ bioassay systems in poster presentations at the 11th Annual Meeting of the International Society of Stem Cell Research (ISSCR), the largest forum for stem cell and regenerative medicine professionals from around the world, held last week in Boston, Massachusetts. Dr. Hai-Qing Xian, Senior Scientist, presented VistaGen’s poster entitled “Cardiotoxicity Assessment of Anti-Cancer Kinase Inhibitors using Human Pluripotent Stem Cell-Derived Cardiomyocyte Based Assays,” which detailed important developments demonstrating that…

MondayJun 17, 2013 10:29 am

Tri-Tech Holding, Inc. (TRIT) Announces Appointments and Retirements

Tri-Tech Holding recently announced some changes to its management. The company has appointed Brian McLellan as the General Manager of Tri-Tech Infrastructure, LLC, and also announced the retirement of former General Manager, Mr. James Schwartz. "Mr. Schwartz has been a valuable employee and a sincere friend to the Company. While we will miss him, we are glad that James will be able to spend more time away from work upon his retirement,” remarked Tri-Tech’s CFO and President, Mr. Phil Fan. "Mr. McClellan joined us in 2012 and served as Technical Director since. With his extensive experience, we are confident that…

MondayJun 17, 2013 9:47 am

The Aristocrat Group Corp. (ASCC) Launches Brand-Building Wholesale Initiative

The Aristocrat Group Corp. announced today that its wholesale subsidiary, TOP Shelf Distributing, is currently in the process of obtaining wholesaler licensing in one of the country’s top markets in the $21.3 billion U.S. spirits industry. Expanding business via distribution deals with international distillers and brewers is an important part of the company’s overall business strategy. The first product slated for wholesale by TOP Shelf is RWB Ultra-Premium Handcrafted Vodka, an all-American spirit with federal approval to advertise its gluten-free status right on the label. It’s scheduled for release in August. ASCC’s plans for its wholly owned distributor go much…

MondayJun 17, 2013 9:07 am

DoMark International Inc. (DOMK) Reports Strong Demand for New IRCharger Cover

DoMark International, a leader in infrared/solar charging systems for Apple (AAPL) and Samsung (KOSCOM:SSNFL) devices, today announced that it has received 158,000 orders for its new IRCharger case for Apple iPhones and Samsung Galaxy Slll and S4 smartphones prior to its upcoming global launch date. “Our global distribution partners have been receiving great interest for the product from retailers and we are expecting to be able to announce many more orders shortly,” Domark CEO Andy Ritchie said. The new IR Charger Case, which has a release date of August 1, 2013, features innovative patent pending INFRASOLTM technology utilizing infrared and…

MondayJun 17, 2013 8:20 am

Intelimax (IXMD) – Grant of Stock Options

Intelimax Media Inc. is pleased to announce that it has granted incentive stock options to a consultant of the Company to purchase up to 200,000 common shares of the Company pursuant to a shareholder approved Share Option Plan. The options are exercisable on or before June 17, 2018, at an exercise price of $0.18 per share. Let us hear your thoughts below:

SaturdayJun 15, 2013 9:50 pm

Monster Arts, Inc. (MONT) Iconosys Receives Trademark for Word Bully®, Anti-Cyberbullying Smartphone App

Iconosys, subsidiary of Monster Arts and a developer of family safety, lifestyle, and entertainment Smartphone apps, today reported the formal registration of its trademark smartphone app, Word Bully®, as well as received trademark status for Iconosys®. This registration bolsters the company's portfolio of intellectual property, protecting the company’s brands, technologies, apps, Web sites, merchandise, and licensing agreements. Word Bully® was designed to address “cyberbullying,” which the company says is becoming more common in younger demographics, prompting legislation and awareness campaigns to thwart the practice. The app gives parents, guardians, and/or local authorities control over the content and tone of text…

FridayJun 14, 2013 2:55 pm

WordLogic Corp. (WLGC) Receives U.S. Patent Allowance

Predictive intelligence technology company, WordLogic announced today that the U.S. Patent Office has granted a patent application, No. 11/036267, Titled; method, system, apparatus and computer-readable media for directing input associated with a keyboard-type device. All claims within the accepted patent application were allowed to include the broadest of claims. This company’s focus is on the overall development, marketing, licensing, and selling of advanced predictive platform software that's been specifically designed to increase information discovery and overall text input. With a patent portfolio that includes patents currently pending, WordLogic has been referenced regularly by corporate heavyweights such as Google, Microsoft, Veveo…

FridayJun 14, 2013 2:35 pm

International Stem Cell Corp. (ISCO) Applies Broad Stem Cell IP Portfolio to Three Key Markets

Biotech small-cap International Stem Cell Corp. uses unfertilized eggs to develop therapies to treat diseases of the brain, liver, and the eye. By using unfertilized eggs to create human pluripotent stem cells, the company’s core technology avoids the controversial use of viable human embryos. As noted above, the company is focused on three key markets: The company is in pre-clinical stages for its treatment of Parkinson’s disease. Parkinson's disease is the second most prevalent neurodegenerative diseases, effecting 4 percent of the population over the age of 50. The company says the origin of the disease and its relative localization in…

FridayJun 14, 2013 1:47 pm

Ventripoint Diagnostics, Inc. (VPTDF) Seeks to Expand AngeloVMS™ Applications, Triple Sales by 2014

Ventripoint Diagnostics is the creator of what company management believes to be the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. The company created the blueprint to achieve its application expansion and goals for continued financial growth, supported by key management. The first applications of the company’s Angelo (VMS™) analysis system are congenital heart disease and pulmonary arterial hypertension. Ventripoint has been granted Canada and Europe (CE Mark) approval for the sale of VMS and is awaiting the U.S.-FDA marketing clearance as well. VMS was developed to address several issues associated with current heart diagnostics and…

Site Search

Company Search